Ebstein's anomaly of the tricuspid valve history

Ebsteins anomaly of the tricuspid valve Microchapters
Home
Patient Information
Overview
Historical Perpective
Classification
Pathophysiology
Causes
Differentiating Ebstein's Anomaly from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography
CT
MRI
Other Imaging Findings
Other diagnostic studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Ebstein's anomaly of the tricuspid valve history On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ebstein's anomaly of the tricuspid valve history All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ebstein's anomaly of the tricuspid valve history
CDC on Ebstein's anomaly of the tricuspid valve history
Ebstein's anomaly of the tricuspid valve history in the news
Blogs on Ebstein's anomaly of the tricuspid valve history
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Ebstein's anomaly of the tricuspid valve history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]

History

• Presentation depends greatly on the degree of apical displacement of the tricuspid valve leaflet as well as the degree of dysfunction of the tricuspid valve. If the tricuspid valve is severely deformed, fetal hydrops may occur. If the valve is functioning, patients may remain symptom free for many years.

• The majority of patients have dyspnea and cyanosis (40%) but some may be asymptomatic.

• Palpitations may occur secondary to SVTs (supraventricular tachycardia) and WPW (Wolff-Parkinson-White syndrome) (8%).

• Growth and development are normal.